期刊文献+

C-12蛋白芯片检测宣威地区肺癌的临床意义

Clinical Significance of C-12 Protein Chip in Detection of Lung Cancer in Xuanwei Region
下载PDF
导出
摘要 目的探讨C-12蛋白芯片对云南省宣威地区肺癌患者的诊断价值.方法 (1)应用C-12蛋白芯片检测系统分别检测实验组40例肺癌患者,对照组38例肺良性病变血清中12种肿瘤标志物(CA-199、NSE、CEA、CA-242、CA-125、CA-153、AFP、Feritin、free-PSA、PSA、β-HCG、HGH)的水平.分别计算出实验组和对照组血清C-12的阳性率及临床评价指标.结果实验组的C-12的阳性率为75%(30/40),显著高于对照组的36.84%(14/38),肺癌组中CEA、CA-199、CA-125、CA-242、CA-153血清水平显著高于肺良性病变组.C-12蛋白芯片检测的敏感度为75%(30/40),特异性为63.16%(24/38),准确度为69.23%(54/78).结论云南省宣威地区肺癌患者血清中CEA、CA242、CA125、CA153、CA199阳性率较高.C-12蛋白芯片检测对其有重要的辅助诊断价值.C-12蛋白芯片检测特异度较高,操作方便,费用低廉,可以用于该地区高危人群、住院患者的筛查. Objective To investigate the diagnostic value of C-12 protein chip in detecting lung cancer patients in Xuan Wei region,Yunnan province.Methods The serum levels of l2 tumor markers,including CA199,NSE,CEA,CA242,CA125,CAl53,AFP,ferritin,free-PSA,PSA,β-HCG and HGH,were measured in 40 cases with lung cancer as trial group,38 cases with benign pulmonary lesion by the C-12 protein chip.The positive rate and clinical evaluation indexes of C-12 in trial group and benign pulmonary lesion group were calculated.Results The positive rates of C-12 were 75%(30/40) and 36.84%(14/38) in trial group and benign pulmonary lesion group,respectively.The trial group had significantly higher positive rate than benign pulmonary lesion group.The serum levels of the tumor of markers,including CEA,CA-199,CA-125,CA242,CA-153 in the trial group is significantly higher than the benign pulmonary lesion group.The sensitivity rate of C-12 was 75%(30/40),the specificity rate of C-12 was 63.16%(24/38),and the accuracy rate of C-12 was 69.23%(54/78).Conclusions The positive rates of CEA,CA242,CA125,CA153,CA199 is higher in lung cancer patients in Yunnan Xuanwei region.C-12 protein chip has important diagnostic value for lung cancer.C-12 protein chip has high specificity,easy operation,and low expense,so can be used to screen lung cancer in high risk population and hospitalized patients in this region.
出处 《昆明医科大学学报》 CAS 2013年第1期96-100,共5页 Journal of Kunming Medical University
关键词 肺部肿瘤 肿瘤标志物 C-12蛋白芯片检测系统 Lung cancer Tumor marker 12-tumor-marker protein biochip detective system
  • 相关文献

参考文献14

  • 1毛友生,高燕宁,赫捷,张德超,程书钧.肺癌分子生物学特性与转移和预后的关系[J].中华肿瘤杂志,2006,28(8):632-634. 被引量:60
  • 2SANDERS GHW,MANZ A. Chip-based microsytems for genomic and proteomic analysis [J ]. Trends And Chem, 2000, 19 (6):364 - 378.
  • 3WEINBERGER S R, DALMASSO E A, FUNG E T. Curr- ent achievements using protein chip array technology [ J ]. Curr Opin Chem BM,2002,6 ( 1 ):86 - 91.
  • 4RUBIN R B, MERCHANTM A. Rapid protein profiling s- ystem that speeds study of cancer and other diseases [ J ]. Am Clin Lab, 2000,19 (8) : 28 - 29.
  • 5MURAKI M,TOHDA Y. Asiessment of serum CYFRA21- 1 in lung cancer J[J]. Cancer, 1996,77 ( 7 ) : 1 274 - 1 277.
  • 6SCHNEDDER J, KATZN. Comparison of the tumor marker Mz-pk,CEA,CYFRA21-1 ,NSE and SCC in the diagnosis of Lung cancer[ J ]. Anticancer Res, 2000,20(6 ) : 5 053 - 5 058.
  • 7SHURE D. FiberoPtic bronchoscopy-diagnostic applicati- ons[J]. Clinics in Chest Medicine, 1987,8:1 - 3.
  • 8LAIN S, KENNEDY T, UNGER, et al. Locolization of bro- nchial intraepithelial neoplastic lesions by fluoreseence bronchoscopy[J]. Chest, 1998,113:696 - 702.
  • 9BOECK S,STIEBER P,HOLDENRIEDER S,et al. Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer[J]. Oncology,2006,70(4):255 - 264.
  • 10郑三.多肿瘤标志物蛋白芯片检测系统对肺癌的诊断价值[J].中国热带医学,2006,6(5):783-784. 被引量:4

二级参考文献25

  • 1彭忠民,罗静,王潍博,王晓航,陈景寒,兰守敏.耐药相关基因表达对Ⅲ期非小细胞肺癌新辅助化疗的临床预测价值探讨[J].癌症,2004,23(8):963-967. 被引量:7
  • 2高禹舜,张德超,赫捷,孙克林,张大为,张汝刚.Ⅰ期非小细胞肺癌的诊断与外科治疗[J].中华肿瘤杂志,2005,27(1):52-55. 被引量:16
  • 3张德超,毛友生,黄国俊.中国肺癌外科治疗概况与进展[J].中国肺癌杂志,2005,8(6):557-562. 被引量:28
  • 4戴旭东 林英姬 孙喜文.全球与我国肺癌流行态势及防治对策研究进展[J].中国肺癌杂志,2002,5(11):2-2.
  • 5Von Eggeling F, Davies H, Lomas L, et al. Tissue- specific microdissection coupled with PreteinChip array technologies, applications in cancer research[J]. Biotechniques,2000,29(5) : 1066 - 1070.
  • 6Weinberger SR, Dalmasso EA, Fung ET.Current achievements using ProteinChip Array technology[J]. Curr Opin Chem Biol,2002,6(1) :86 - 91.
  • 7Rubin RB, Merchant M. A rapid protein profiling system that speeds study of cancer and other diseases[J]. Am Clin Lab,2000,19(8) :28 - 29.
  • 8Schneider J, Peltri G, Bitterlich N, et al. Fuzzy logic - based tumor marker profiles including a new marker tumor M2 - PK improved sensitivity to the detection of progression in lung cancer patients [ J ].Anticancer Res,2003,23(2A) :899 - 906.
  • 9Foa P, Fomier M, Miceli R, et al. Tumour markers CEA, NSE,SCC,TPA and CYFRA 21.1 in resectable non - small cell lung cancer[J]. Anticancer Res,1999,163-189.
  • 10Diez M, Tones A, Maeslro ML, et al. Prediction of survival and recunence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non - small - cell lung cancer[J]. Br J Cancer, 1996, 73(10) :1248 - 1254.

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部